Stock Market Reviews

Read and share opinions on IXHL (Incannex Healthcare Inc.) stock. Join MyTopStock.com to discover reviews, insights, and discussions from investors about this company's performance in the stock market

Latest News

• Incannex Provides Shareholder Update Highlighting Clinical Progress, Capital Discipline, and EOY 2025 Strategic Focus
  Oct 30, 2025
• Incannex Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Price Requirement
  Oct 22, 2025
• Incannex Reports Positive Results from Phase 2 Clinical Trial of PSX-001 (Psi-GAD) for Generalised Anxiety Disorder
  Aug 26, 2025
• Incannex Healthcare Authorizes $20 Million Share Repurchase Program
  Aug 22, 2025
• Stonegate Updates Coverage on Incannex Healthcare Inc. (IXHL) 3Q 2025 - Update
  Aug 19, 2025
• Incannex Healthcare Inc. (IXHL) Receives Positive Patient-Reported Outcomes For IHL-42X in Obstructive Sleep Apnoea
  Aug 17, 2025
• Incannex Receives Positive Patient-Reported Outcomes and Compelling Phase 2 Efficacy Data for IHL-42X in Obstructive Sleep Apnoea
  Aug 8, 2025
• Incannex Confirms Strong Cash Position; No Plans or Requirement to Fully Utilise ATM in Near Term
  Jul 31, 2025
• Incannex Reports Positive Topline Results from RePOSA Phase 2 Trial of IHL-42X
  Jul 30, 2025
• Incannex Healthcare Expands Clinical Advisory Board to Support Obstructive Sleep Apnea Program with Appointment of Dr. Charlene E. Gamaldo
  Jul 25, 2025
• Incannex Healthcare Expands Clinical Advisory Board to Support Obstructive Sleep Apnea Program with Appointment of Dr. Douglas B. Kirsch
  Jun 24, 2025
• Incannex achieves key milestone with database lock for RePOSA Phase 2 trial of IHL-42X
  Jun 18, 2025
• Incannex Healthcare Forms Joint Venture with Mind Medicine Australia to Expand Access to Psychedelic-Assisted Therapy
  Jun 17, 2025
• Incannex Healthcare Cancels All Outstanding Series A Warrants Following Strategic ATM Execution
  Jun 12, 2025
• Incannex Healthcare Inc. Expands IHL-42X Clinical Advisory Board with Appointments of Four Industry and Academic Leaders to Advance Obstructive Sleep Apnea (OSA) Program
  Jun 3, 2025
• Incannex Healthcare Inc. Advances IHL-42X RePOSA Trial to Phase 3 Following FDA Protocol Clearance
  May 29, 2025
• Incannex Healthcare Inc. Enters Agreement to Cancel Remaining Series A Warrants, Eliminating Up to 347.2 Million Shares from Potential Dilution Ahead of IHL-42X Phase 2 Topline Results
  May 28, 2025